中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2012年
10期
2032-2034
,共3页
汪理%刘涛%勾善淼%周伟%王统玲%陈立波%王春友
汪理%劉濤%勾善淼%週偉%王統玲%陳立波%王春友
왕리%류도%구선묘%주위%왕통령%진립파%왕춘우
胰腺癌%糖原合成激酶-3β%核因子-κB%RNA干扰
胰腺癌%糖原閤成激酶-3β%覈因子-κB%RNA榦擾
이선암%당원합성격매-3β%핵인자-κB%RNA간우
Pancreatic carcinoma%Glycogen synthase kinase-3β%Nuclear factor-κB%RNA interference
目的 观察沉默糖原合成激酶-3β(GSK-3β)对人胰腺癌细胞株PANC-1增殖和存活的影响,探讨其分子机制.方法 实验分组如下:阴性对照组为未转染的PANC-1细胞;载体对照组为稳定转染control shRNA的PANC-1细胞;实验组为稳定转染GSK-3β shRNA的PANC-1细胞.噻唑蓝(MTT)比色法连续7d检测各组细胞的吸光度(A)值,并绘制出细胞的生长曲线;流式细胞仪(FCM)检测各组细胞的凋亡和周期;电泳迁移率实验(EMSA)检测各组细胞中核因子(NF)-κB的DNA结合活性.结果 转染GSK-3β短发卡RNA (shRNA)的实验组PANC-1细胞生长速度明显减慢;实验组细胞的早期凋亡比例为(5.38±0.33)%,较阴性对照组(1.71±0.08)%和载体对照组(1.68 ±0.11)%显著升高(P<0.05);实验组中G0/G1期细胞比例为(60.02±1.99)%,较阴性对照组(46.56±3.13)%和载体对照组(46.04±2.92)%显著升高(P<0.05),发生明显的G1期阻滞;实验组细胞中代表NF-κB复合体数量的条带A值为2186.37±225.51,与阴性对照组(4005.39±203.64)和载体对照组(3793.32 ±310.34)比较显著减少(P<0.05);而上述对照组组间差异无统计学意义(P>0.05).结论 靶向抑制GSK-3β可抑制胰腺癌细胞增殖,诱导其凋亡,其机制可能与下调NF-κB的转录活性有关.
目的 觀察沉默糖原閤成激酶-3β(GSK-3β)對人胰腺癌細胞株PANC-1增殖和存活的影響,探討其分子機製.方法 實驗分組如下:陰性對照組為未轉染的PANC-1細胞;載體對照組為穩定轉染control shRNA的PANC-1細胞;實驗組為穩定轉染GSK-3β shRNA的PANC-1細胞.噻唑藍(MTT)比色法連續7d檢測各組細胞的吸光度(A)值,併繪製齣細胞的生長麯線;流式細胞儀(FCM)檢測各組細胞的凋亡和週期;電泳遷移率實驗(EMSA)檢測各組細胞中覈因子(NF)-κB的DNA結閤活性.結果 轉染GSK-3β短髮卡RNA (shRNA)的實驗組PANC-1細胞生長速度明顯減慢;實驗組細胞的早期凋亡比例為(5.38±0.33)%,較陰性對照組(1.71±0.08)%和載體對照組(1.68 ±0.11)%顯著升高(P<0.05);實驗組中G0/G1期細胞比例為(60.02±1.99)%,較陰性對照組(46.56±3.13)%和載體對照組(46.04±2.92)%顯著升高(P<0.05),髮生明顯的G1期阻滯;實驗組細胞中代錶NF-κB複閤體數量的條帶A值為2186.37±225.51,與陰性對照組(4005.39±203.64)和載體對照組(3793.32 ±310.34)比較顯著減少(P<0.05);而上述對照組組間差異無統計學意義(P>0.05).結論 靶嚮抑製GSK-3β可抑製胰腺癌細胞增殖,誘導其凋亡,其機製可能與下調NF-κB的轉錄活性有關.
목적 관찰침묵당원합성격매-3β(GSK-3β)대인이선암세포주PANC-1증식화존활적영향,탐토기분자궤제.방법 실험분조여하:음성대조조위미전염적PANC-1세포;재체대조조위은정전염control shRNA적PANC-1세포;실험조위은정전염GSK-3β shRNA적PANC-1세포.새서람(MTT)비색법련속7d검측각조세포적흡광도(A)치,병회제출세포적생장곡선;류식세포의(FCM)검측각조세포적조망화주기;전영천이솔실험(EMSA)검측각조세포중핵인자(NF)-κB적DNA결합활성.결과 전염GSK-3β단발잡RNA (shRNA)적실험조PANC-1세포생장속도명현감만;실험조세포적조기조망비례위(5.38±0.33)%,교음성대조조(1.71±0.08)%화재체대조조(1.68 ±0.11)%현저승고(P<0.05);실험조중G0/G1기세포비례위(60.02±1.99)%,교음성대조조(46.56±3.13)%화재체대조조(46.04±2.92)%현저승고(P<0.05),발생명현적G1기조체;실험조세포중대표NF-κB복합체수량적조대A치위2186.37±225.51,여음성대조조(4005.39±203.64)화재체대조조(3793.32 ±310.34)비교현저감소(P<0.05);이상술대조조조간차이무통계학의의(P>0.05).결론 파향억제GSK-3β가억제이선암세포증식,유도기조망,기궤제가능여하조NF-κB적전록활성유관.
Objective To investigate the effects of glycogen synthase kinase-3 β (GSK-3β) RNA interference on proliferation of pancreatic adenocarcinoma cells and to explore the molecular mechanism involved in the procedure.Methods PANC-1 cells stably expressing GSK-3β shRNA and control shRNA served as the experimental group and the vector control group respectively,and the cells that were not transfected as the negative control group.The growth curves of PANC-1 cells were designed by MTT assay.The apoptosis and cycle of cells were analyzed by using flow cytometry (FCM).The nuclear factor-κB (NF-κB) DNA binding activity was detected by using electrophoretic mobility shift assay (EMSA) analysis of nuclear extracts.Results As compared with control groups,the growth capability of PANC-1 cells in experimental group was decreased notably.In experimental group,the early apoptosis rate [(5.38 ± 0.33) %] was significantly higher than the negative control group [(1.71 ± 0.08) %] and the vector control group [(1.68 ± 0.11) %] (P < 0.05).In experimental group,the percentage of cells in G0 and G1 phases [(60.02 ± 1.99)%] was higher than in the negative control group [(46.56 ±3.13)%] and the vector control group [(46.04 ± 2.92) %],while that in S phase cell was lower (P < 0.05).Cell cycle was arrest at G1 phase.In experimental group,the band intensity index which was described as the NF-κB complex number was (2186.37 ±225.51),which was lower than in the negative control group [(4005.39 ±203.64)] and the vector control group [(3793.32 ±310.34)],but there was no significant difference between the negative control group and the vector control group (P > 0.05).Conclusion GSK-3 β RNA interference may inhibit the proliferation and survival of pancreatic adenocarcinoma cells via NF-κB signal pathway.